Surgical, clinical, and functional outcomes of transoral robotic surgery used in sleep surgery for obstructive sleep apnea syndrome: A systematic review and meta‐analysis. Issue 7 (16th April 2021)

• Record Type: Journal Article
• Authors: Lechien, Jerome R.; Chiesa‐Estomba, Carlos‐Miguel; Fakhry, Nicolas; Saussez, Sven; Badr, Ibrahim; Ayad, Tareck; Chekkoury‐Idrissi, Younes; Melkane, Antoine E.; Bahgat, Ahmed; Crevier‐Buchman, Lise; Blumen, Marc; Cammaroto, Giovanni; Vicini, Claudio; Hans, Stéphane
• Is Part Of: Head & neck. Volume 43:Issue 7(2021)
• Page Start: 2216
• Page End: 2239
• Publication Date: 2021-04-16
• Subjects: apnea -- outcome -- review -- robot -- robotic -- sleep -- surgery -- tongue -- tonsil -- TORS; Head -- Diseases -- Periodicals; Neck -- Diseases -- Periodicals; Head -- Periodicals; Neck -- Periodicals; Face -- Periodicals; 617.51059
• DOI: 10.1002/hed.26702
• Languages: English
• ISSNs: 1043-3074

Abstract

Abstract: We investigated safety and efficacy of transoral robotic surgery (TORS) for base of tongue (BOT) reduction in obstructive sleep apnea syndrome (OSAS) patients. PubMed, Cochrane Library, and Scopus were searched. A meta‐analysis was performed. Random effects models were used. Thirty‐one cohorts met our criteria (1693 patients). The analysis was based mostly on retrospective studies. The summary estimate of the reduction of Apnea–Hypoxia Index (AHI) was 24.25 abnormal events per hour (95% CI: 21.69–26.81) and reduction of Epworth Sleepiness Scale (ESS) was 7.92 (95% CI: 6.50–9.34). The summary estimate of increase in lowest O2 saturation was 6.04% (95% CI: 3.05–9.03). The success rate of TORS BOT reduction, either alone or combined with other procedures, was 69% (95% CI: 64–79). The majority of studies reported low level of evidence but suggested that TORS BOT reduction may be a safe procedure associated with improvement of AHI, ESS, and lowest O2 saturation.